On
The event highlights the very keen attention from the US investment community currently in new biopharma technologies and its significantly increased interest and investment in the mRNA field.
© Modular Finance, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.88 SEK | -1.01% | -3.29% | -23.24% |
04-29 | Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-14 | Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace | CI |
On
The event highlights the very keen attention from the US investment community currently in new biopharma technologies and its significantly increased interest and investment in the mRNA field.
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-23.24% | 8.53M | |
-3.21% | 90.45B | |
+3.95% | 41.45B | |
-10.51% | 33.57B | |
+60.58% | 25.73B | |
-20.09% | 14.73B | |
-8.92% | 12.82B | |
-11.46% | 11.7B | |
-43.05% | 11.44B | |
+5.17% | 8.79B |